Navigation Links
Mirena IUD Lawsuit Allowed to Proceed in State Court, After Judge Rules Certain Healthcare Defendants Weren’t Misjoined, Bernstein Liebhard LLP Reports
Date:7/16/2014

New York, New York (PRWEB) July 16, 2014

A Mirena lawsuit (http://www.themirenalawsuitcenter.com/) filed on behalf of a woman who allegedly died due to serious complications associated with the IUD will be allowed to proceed in state court, Bernstein Liebhard LLP reports. In an Order dated July 10th, Chief Judge Gary L. Sharpe of the U.S. District Court, Northern District of New York, remanded the case to Albany County Supreme Court, where it was originally filed, after finding that certain healthcare defendants were not misjoined, as they are indispensable parties and sufficiently related to the suit’s product liability claims involving Bayer Healthcare Pharmaceuticals. (Humphrey v. Riley, et al., No. 1:14-80)

“This case is of great interest to our Firm, as we are representing a number of women who are also alleged to have experienced serious Mirena complications,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Mirena lawsuit evaluations to women who were seriously harmed, allegedly due to spontaneous migration of the IUD.

Mirena IUD Litigation
Court documents indicate that more than 1,300 Mirena IUD lawsuits have been filed in courts around the country on behalf of women who were allegedly harmed by spontaneous migration of the birth control device. These cases include at least 776 that are pending in a multicounty litigation underway in New Jersey’s Bergen County Superior Court, where Bernstein Liebhard LLP is actively filing claims. (In Re: Mirena Litigation; Case No. 297) An additional 612 claims have been filed in a federal multidistrict litigation underway in U.S. District Court, Southern District of New York. (In re: Mirena IUD Products Liability Litigation, MDL No. 2434)

All of these lawsuits similarly allege that victims of Mirena migration have suffered a number of serious injuries, including uterine perforations, scarring, infections, and infertility. Among other things, plaintiffs claim that the labeling for Mirena only notes that the device may migrate if the uterus is perforated upon insertion. It does not mention that the Mirena IUD may migrate long after it was correctly inserted by a doctor.

Mirena was first approved as a contraceptive by the U.S. Food & Drug Administration (FDA) in 2000, which went on to expand its approved uses in 2009 to include treatment of heavy menstrual bleeding in women who wish to use an IUD for birth control. The device is a long-acting contraceptive that is placed directly into the uterus, where it emits a synthetic form of progesterone for up to five years. In December 2009, the FDA issued a warning letter to Bayer after finding that one of its Mirena promotions overstated the IUD’s benefits and downplayed its risks.

Women who allegedly suffered serious Mirena complications due to spontaneous IUD migration may be entitled to file their own Mirena lawsuit. To learn more, please visit Bernstein Liebhard LLP’s website, or the Firm's Facebook page: https://www.facebook.com/mirenalawsuithelp. For a free and confidential Mirena case review, please call 800-511-5092.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.themirenalawsuitcenter.com/
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/miren-iud-lawsuit/mirena-complications/prweb12023226.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Mirena IUD Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in New Jersey Mirena Lawsuits
2. Bernstein Liebhard LLP Notes Filing of New Mirena Lawsuit Alleging Spontaneous IUD Migration, other Complications
3. Mirena IUD Lawsuit News: Rising Popularity of Mirena May Be Cause for Concern, Reports Bernstein Liebhard LLP
4. Mirena IUD Birth Control Device Perforates Nevada Woman's Uterus Prompting Need for Removal Surgery, Alleges Lawsuit Filed by Parker Waichman LLP
5. Mirena Lawsuits Continue to Mount, As Bernstein Liebhard LLP Notes Filing of New Claim on Behalf of Alleged Victim of Mirena Complications
6. DrugNews: Judge Refuses Bayer Request to Dismiss Mirena Lawsuit
7. Tennessee Woman Suffers Severe, Permanent Injuries from Mirena IUD, Parker Waichman LLP Alleges in Lawsuit Filed on Her Behalf
8. Mirena Lawsuits Mount, as Bernstein Liebhard LLP Notes More than 400 Mirena IUD Lawsuit Filings in State, Federal Litigations
9. Mirena IUD Lawsuit Help Update: Resource4thePeople Comments on New Developments in State and Federal Court Litigation
10. Injury Lawyer Comments on the Growing Number of Mirena IUD Lawsuits
11. U.S. Federal Panel Vacates Order to Transfer Mirena Lawsuit to New York Litigation, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... , ... August 18, 2017 , ... The Golseth Agency, ... the Dallas/Fort Worth area, is spearheading a regional charity campaign organized to provide support ... In early June of this year, Christina and her children returned from out of ...
(Date:8/18/2017)... , ... August 18, 2017 , ... ... highly trained practitioners specializing in bioidentical hormone replacement therapy and integrative medicine, has ... imbalance and conditions of aging, such as menopause, andropause, thyroid disorder and adrenal ...
(Date:8/18/2017)... ... August 18, 2017 , ... Alcovit, a lime-flavored beverage ... up its marketing efforts with its product now available through Jet.com. , After ... public. The effervescent powdered drink is designed to quickly detox the body thereby avoiding ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... ... numbers and call tracking and monitoring solutions, announced today the launch of a ... include a modern navigation and aesthetic, fully responsive design, and an enhanced search ...
(Date:8/18/2017)... ... August 18, 2017 , ... “Dangerous Inheritance”: a mystery about ... Winters. Diane is from Southwest Nebraska where she was raised on a farm. ... The story is fictional, but the friendships and mantra of ‘neighbors helping neighbors’ ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... -- Axium Pharmaceuticals Inc., the creator of the drug Truveta for ... of an IPO. The United States ... of a prescription epilepsy drug being $450.00-$1200.00 for a one month supply. ... AXIUM PHARMACEUTICALS, INC ... staggering figure is the fact that Americans spent $42 billion on anxiety ...
(Date:8/14/2017)... Israel , Aug. 15, 2017  BrainStorm ... adult stem cell technologies for neurodegenerative diseases, announced financial ... "We are in ... 3 trial to investigate NurOwn ® in ALS," ... Officer of BrainStorm. "We have agreements with Mass. General ...
(Date:8/8/2017)... -- BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company focused ... for the second quarter ended June 30, 2017. ... and to date: ... Company,s lead project, BL-8040: Announced plans ... novel stem cell mobilization treatment for autologous bone-marrow transplantation ...
Breaking Medicine Technology: